{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:19:20Z","timestamp":1791094760412,"version":"4.1.0"},"reference-count":274,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016170","name":"Japan Blood Products Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["17933604"],"award-info":[{"award-number":["17933604"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005926","name":"Cosmetology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17824562"],"award-info":[{"award-number":["17824562"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19111560"],"award-info":[{"award-number":["19111560"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jaci.2020.02.013","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T08:13:09Z","timestamp":1586160789000},"page":"1031-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"title":["Autoimmune bullous skin diseases, pemphigus and pemphigoid"],"prefix":"10.1016","volume":"145","author":[{"given":"Shohei","family":"Egami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.02.013_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.02.013_bib2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib3","series-title":"Dermatology","article-title":"Pemphigus","author":"Amagai","year":"2017"},{"key":"10.1016\/j.jaci.2020.02.013_bib4","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2020.02.013_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaci.2020.02.013_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"10.1016\/j.jaci.2020.02.013_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0923-1811(99)00016-X","article-title":"Autoimmunity against desmosomal cadherins in pemphigus","volume":"20","author":"Amagai","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/jid.2014.151","article-title":"Immunological and statistical studies of anti-BP180 antibodies in paraneoplastic pemphigus","volume":"134","author":"Tsuchisaka","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(84)70025-9","article-title":"Pemphigus erythematosus: presentation of four cases and review of literature","volume":"10","author":"Amerian","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamadermatol.2013.5244","article-title":"Two cases of pemphigus vegetans with IgG anti-desmocollin 3 antibodies","volume":"149","author":"Saruta","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000468919","article-title":"Atypical clinical and serological manifestation of pemphigus vegetans: a case report and review of the literature","volume":"9","author":"Mergler","year":"2017","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/abd1806-4841.20142459","article-title":"Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG\/IgA pemphigus","volume":"89","author":"Porro","year":"2014","journal-title":"Ana Bras Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0738-081X(98)00010-8","article-title":"Drug-induced pemphigus","volume":"16","author":"Brenner","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib17","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.2353\/ajpath.2010.100483","article-title":"Autoimmunity to desmocollin 3 in pemphigus vulgaris","volume":"177","author":"Mao","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2020.02.013_bib18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajpath.2010.10.016","article-title":"IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion","volume":"178","author":"Rafei","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2020.02.013_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2020.02.013_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/1346-8138.12675","article-title":"Cooperative Group on Fogo Selvagem Research. Update on fogo selvagem, an endemic form of pemphigus foliaceus","volume":"42","author":"Aoki","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.1993.01680220081019","article-title":"Pemphigus foliaceus in young women: an endemic focus in the Sousse area of Tunisia","volume":"129","author":"Morini","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-4362.2001.01247.x","article-title":"The incidence of pemphigus in the southern region of Saudi Arabia","volume":"40","author":"Tallab","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-4632.2004.02292.x","article-title":"Spectrum of autoimmune bullous diseases in Kuwait","volume":"43","author":"Nanda","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1468-3083.2002.00384.x","article-title":"Increased\u00a0incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans","volume":"16","author":"Hahn-Ristic","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/1523-1747.ep12612836","article-title":"Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women","volume":"104","author":"Bastuji-Garin","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-4362.1998.00428.x","article-title":"Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily","volume":"37","author":"Micali","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2340\/0001555562491496","article-title":"Pemphigus: an epidemiological study of patients treated\u00a0in\u00a0Finnish hospitals between 1969 and 1978","volume":"62","author":"Hietanen","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jaci.2020.02.013_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2016.06.055","article-title":"Remarkable\u00a0differences in the epidemiology of pemphigus among two ethnic\u00a0populations in the same geographic region","volume":"75","author":"Kridin","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archderm.1980.01640330073017","article-title":"Pemphigus in Hartford County, Connecticut, from 1972 to 1977","volume":"116","author":"Simon","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaut.2008.08.003","article-title":"Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity","volume":"31","author":"Culton","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2020.02.013_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM200007063430104","article-title":"The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research","volume":"343","author":"Warren","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib33","first-page":"1109","article-title":"Incidence of pemphigus vulgaris exceeds that of pemphigus foliaceus in a region where pemphigus foliaceus is endemic: analysis of a 21-year historical series","volume":"86","author":"Goncalves","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2133.2006.07302.x","article-title":"Clinical and serological follow-up studies of endemic pemphigus foliaceus (fogo selvagem) in Western Parana, Brazil (2001-2002)","volume":"155","author":"Empinotti","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jid.2014.430","article-title":"IgE anti-LJM11 sand fly salivary antigen may herald the onset of fogo selvagem in endemic Brazilian regions","volume":"135","author":"Qian","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4049\/jimmunol.1502233","article-title":"Overlapping IgG4 responses to self- and environmental antigens in endemic pemphigus foliaceus","volume":"196","author":"Qian","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2133.2009.09207.x","article-title":"Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles","volume":"161","author":"Abida","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/aje\/155.3.249","article-title":"Possible relation of Tunisian pemphigus with traditional cosmetics: a multicenter case-control study","volume":"155","author":"Bastuji-Garin","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaci.2020.02.013_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2004.05.002","article-title":"The immunogenetics of pemphigus vulgaris","volume":"4","author":"Gazit","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2020.02.013_bib40","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major\u00a0histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.02.013_bib41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2133.2012.11040.x","article-title":"Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.17191","article-title":"Subtype-specific inherited predisposition to pemphigus in the Chinese population","volume":"180","author":"Zhang","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib43","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/bjd.16022","article-title":"HLA class II alleles of susceptibility and protection in Brazilian and Dutch pemphigus foliaceus","volume":"178","author":"de Sena Nogueira Maehara","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1\u221703 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2020.02.013_bib45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II alleles in\u00a0Chinese\u00a0patients with paraneoplastic pemphigus","volume":"158","author":"Liu","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09629350310001619735","article-title":"Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus","volume":"12","author":"Torzecka","year":"2003","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jaci.2020.02.013_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.humimm.2012.02.001","article-title":"Tumor necrosis factor-alpha -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus","volume":"73","author":"Mosaad","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00403-004-0528-6","article-title":"Cytokine polymorphisms in patients with pemphigus","volume":"296","author":"Eberhard","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2020.02.013_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1468-3083.2009.03260.x","article-title":"TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population","volume":"24","author":"Javor","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib50","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humimm.2005.11.004","article-title":"Pemphigus vulgaris is associated with the transporter associated with antigen processing (TAP) system","volume":"66","author":"Slomov","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-4362.2001.01083.x","article-title":"TNFalpha and IL-6 are mediators in the blistering process of pemphigus","volume":"40","author":"Lopez-Robles","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.164.1.522","article-title":"Immune modulation in pemphigus vulgaris: role of CD28 and IL-10","volume":"164","author":"Toto","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.13433","article-title":"Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis and type I diabetes","volume":"172","author":"Parameswaran","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/ced.12634","article-title":"Pemphigus and associated comorbidities: a cross-sectional study","volume":"40","author":"Heelan","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1684\/ejd.2017.3060","article-title":"Comorbid autoimmune diseases in patients with pemphigus: a nationwide case-control study in Taiwan","volume":"27","author":"Chiu","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib56","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaci.2020.02.013_bib57","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.137.9.2835","article-title":"Defining the role of complement in experimental pemphigus vulgaris in mice","volume":"137","author":"Anhalt","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1172\/JCI114426","article-title":"Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb\/c mice","volume":"85","author":"Rock","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib59","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI8748","article-title":"Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus","volume":"105","author":"Amagai","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib60","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib61","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib62","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/labinvest.3780168","article-title":"Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy","volume":"80","author":"Sato","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib63","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/jid.2008.339","article-title":"Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies","volume":"129","author":"Mao","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib64","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2133.2011.10463.x","article-title":"IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis","volume":"165","author":"Oktarina","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib65","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1074\/jbc.M109.087999","article-title":"p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis","volume":"285","author":"Jolly","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.02.013_bib66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/jid.2013.224","article-title":"MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris","volume":"134","author":"Mao","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib67","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1074\/jbc.M112.438010","article-title":"A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis","volume":"288","author":"Bektas","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.02.013_bib68","doi-asserted-by":"crossref","first-page":"e50696","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.02.013_bib69","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/sj.jid.5700450","article-title":"Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation","volume":"126","author":"Kawasaki","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib70","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fimmu.2018.01190","article-title":"Non-desmoglein antibodies in patients with pemphigus vulgaris","volume":"9","author":"Amber","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib71","doi-asserted-by":"crossref","first-page":"e57587","DOI":"10.1371\/journal.pone.0057587","article-title":"Pemphigus vulgaris autoantibody profiling by proteomic technique","volume":"8","author":"Kalantari-Dehaghi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.02.013_bib72","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaad.2016.11.039","article-title":"Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus","volume":"76","author":"Lakshmi","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib73","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1074\/jbc.M109.081570","article-title":"Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology","volume":"285","author":"Marchenko","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.02.013_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jid.2019.07.717","article-title":"Autoreactive B cell differentiation in diffuse ectopic lymphoid-like structures of inflamed pemphigus lesions","volume":"140","author":"Zhou","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib75","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jid.2017.05.032","article-title":"Pivotal role of lesional and perilesional T\/B lymphocytes in pemphigus pathogenesis","volume":"137","author":"Yuan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin","volume":"111","author":"Mahoney","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib77","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1172\/JCI57379","article-title":"Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice","volume":"121","author":"Takahashi","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaad.2006.06.007","article-title":"Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies","volume":"56","author":"Cummins","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.1203536","article-title":"Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus","volume":"191","author":"Hata","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib80","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.4049\/jimmunol.182.3.1740","article-title":"A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib81","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib82","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1017\/S0022215112001375","article-title":"Laryngeal involvement in pemphigus vulgaris: a proposed classification","volume":"126","author":"Mahmoud","year":"2012","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jaci.2020.02.013_bib83","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(99)04708-X","article-title":"Oesophageal involvement in pemphigus vulgaris","volume":"354","author":"Gomi","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaci.2020.02.013_bib84","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2230.2006.02132.x","article-title":"Oesophageal involvement\u00a0during attacks in pemphigus vulgaris patients","volume":"31","author":"Calka","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/bjd.14725","article-title":"Evaluation of pharyngo-oesophageal involvement in pemphigus vulgaris and its correlation with disease activity","volume":"176","author":"Okamura","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib86","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1365-2133.2002.04696.x","article-title":"Nail involvement in pemphigus vulgaris","volume":"146","author":"Schlesinger","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib87","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/bjd.17136","article-title":"Fingernail involvement in pemphigus and its correlation with disease severity and other clinicodemographic parameters","volume":"180","author":"De","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib88","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib89","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00408-015-9732-8","article-title":"A systematic review of patients with mucocutaneous and respiratory complications in paraneoplastic autoimmune multiorgan syndrome: Castleman\u2019s disease is the predominant malignancy","volume":"193","author":"Lee","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.jaci.2020.02.013_bib90","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib91","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib92","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mjd.2001.117518","article-title":"Immunofluorescence in dermatology","volume":"45","author":"Mutasim","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdermsci.2016.12.007","article-title":"Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid","volume":"85","author":"Fujio","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib95","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib97","doi-asserted-by":"crossref","first-page":"187864","DOI":"10.1155\/2009\/187864","article-title":"Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up","volume":"2009","author":"Belloni-Fortina","year":"2009","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib98","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/1346-8138.12486","article-title":"Japanese guidelines for the management of pemphigus","volume":"41","author":"Amagai","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib100","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1468-3083.2008.02715.x","article-title":"Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission","volume":"22","author":"Kwon","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/08916934.2014.976629","article-title":"Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity\u00a0and clinical expression in pemphigus vulgaris","volume":"48","author":"Naseer","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaci.2020.02.013_bib102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-015-0278-x","article-title":"Prevalence of pemphigus and pemphigoid autoantibodies in the general population","volume":"10","author":"Prussmann","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2020.02.013_bib103","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","article-title":"Diagnosis and management of pemphigus: recommendations by an International Panel of Experts","volume":"82","author":"Murrell","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.01.062","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review. A\u00a0review of glucocorticoid pharmacology and bone health","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review. Gastrointestinal and endocrinologic side effects","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib106","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2016.02.1240","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review. Infectious complications and vaccination recommendations","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2016.02.1241","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review. Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib108","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib109","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone\u00a0for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaci.2020.02.013_bib110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib111","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1056\/NEJMc1508234","article-title":"Long-term remissions in recalcitrant pemphigus vulgaris","volume":"373","author":"Ahmed","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib112","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2340\/00015555-2116","article-title":"Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens","volume":"95","author":"Wang","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib113","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib114","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib116","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mjd.2000.109297","article-title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","volume":"43","author":"Turner","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1744-9987.12557","article-title":"Evaluating the efficacy of double-filtration plasmapheresis in treating five patients with drug-resistant pemphigus","volume":"21","author":"Higashihara","year":"2017","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaci.2020.02.013_bib118","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2133.2003.05513.x","article-title":"Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber","volume":"149","author":"Luftl","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib119","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamadermatol.2014.3674","article-title":"Intralesional rituximab in the treatment of refractory oral pemphigus vulgaris","volume":"151","author":"Vinay","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00432-010-0874-z","article-title":"Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases","volume":"137","author":"Zhang","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaci.2020.02.013_bib121","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaci.2020.02.013_bib122","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.1992.03480110076037","article-title":"Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation","volume":"267","author":"Fullerton","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.02.013_bib123","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.hemonc.2016.05.003","article-title":"Paraneoplastic pemphigus as a presentation of acute myeloid leukemia: early diagnosis and remission","volume":"10","author":"Siddiqui","year":"2017","journal-title":"Hematol\/Oncol Stem Cell Ther"},{"key":"10.1016\/j.jaci.2020.02.013_bib124","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.det.2011.06.016","article-title":"Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome)","volume":"29","author":"Frew","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2020.02.013_bib125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1346-8138.2010.01192.x","article-title":"Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a\u00a0case\u00a0report and review of cases treated with rituximab","volume":"38","author":"Anan","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib126","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2004.00280.x","article-title":"Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia","volume":"73","author":"Hohwy","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2020.02.013_bib127","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjd.12324","article-title":"Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus","volume":"169","author":"Bech","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib128","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fimmu.2019.00978","article-title":"Current clinical trials in pemphigus and pemphigoid","volume":"10","author":"Izumi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13317-017-0100-y","article-title":"Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment","volume":"8","author":"Du","year":"2017","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.jaci.2020.02.013_bib130","first-page":"1338","article-title":"Successful treatment of pemphigus vulgaris with ofatumumab","volume":"17","author":"Rapp","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib131","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamadermatol.2014.1939","article-title":"Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris","volume":"150","author":"Ellebrecht","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib132","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib133","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fmed.2018.00306","article-title":"Perspective from the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference","volume":"5","author":"Lee","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib134","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2012.06844.x","article-title":"Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis","volume":"1274","author":"Souroujon","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib136","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxr020","article-title":"Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris","volume":"23","author":"Yokoyama","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib137","doi-asserted-by":"crossref","first-page":"e32146","DOI":"10.1371\/journal.pone.0032146","article-title":"Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo","volume":"7","author":"Demidova-Rice","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.02.013_bib138","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00403-018-1824-x","article-title":"Autologous platelet-rich plasma and triamcinolone acetonide intralesional injection in the treatment of oral erosions of pemphigus vulgaris: a pilot study","volume":"310","author":"El-Komy","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2020.02.013_bib139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jaci.2020.02.013_bib140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaci.2020.02.013_bib141","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/09546634.2018.1459034","article-title":"Pemphigoid gestationis: a case series and review of the literature","volume":"29","author":"Cohen","year":"2018","journal-title":"J Dermatol Treatment"},{"key":"10.1016\/j.jaci.2020.02.013_bib142","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.det.2011.03.002","article-title":"Pemphigoid gestationis: pathogenesis and clinical features","volume":"29","author":"Intong","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2020.02.013_bib143","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaad.2010.09.776","article-title":"Dermatitis herpetiformis, part II: diagnosis, management, and prognosis","volume":"64","author":"Bolotin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib144","doi-asserted-by":"crossref","first-page":"g2557","DOI":"10.1136\/bmj.g2557","article-title":"Dermatitis herpetiformis","volume":"348","author":"Jakes","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2020.02.013_bib145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2340\/00015555-1990","article-title":"Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark","volume":"95","author":"Lings","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib146","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib147","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bjd.15232","article-title":"A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence","volume":"177","author":"Ohata","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib148","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-019-1089-2","article-title":"Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients","volume":"14","author":"Genovese","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2020.02.013_bib149","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","article-title":"Anti-p200 pemphigoid","volume":"71","author":"Goletz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib150","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2019.02466","article-title":"Anti-p200 pemphigoid: a systematic review","volume":"10","author":"Kridin","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib151","first-page":"434","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2020.02.013_bib152","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib153","first-page":"317","article-title":"Bullous pemphigoid in Liguria: a 2-year survey","volume":"15","author":"Cozzani","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib154","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland","volume":"153","author":"Gudi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib155","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib156","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib157","first-page":"Cr360","article-title":"Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005","volume":"13","author":"Serwin","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jaci.2020.02.013_bib158","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","article-title":"Bullous pemphigoid in infancy: clinical and epidemiologic characteristics","volume":"58","author":"Waisbourd-Zinman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib159","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.1995.01690200097021","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri.2016.125","article-title":"Human immune system variation","volume":"17","author":"Brodin","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib161","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1741-7015-11-94","article-title":"Age-related autoimmunity","volume":"11","author":"Vadasz","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib162","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib163","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib164","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","article-title":"Mucous membrane pemphigoid and pseudopemphigoid","volume":"111","author":"Thorne","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2020.02.013_bib165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2133.2002.04919.x","article-title":"Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review","volume":"147","author":"Wong","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib166","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08916934.2011.606450","article-title":"Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen","volume":"45","author":"Chen","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaci.2020.02.013_bib167","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"Hubner","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib168","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1\u2217 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.02.013_bib169","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2011.07.002","article-title":"Role of MHC class II genes in the pathogenesis of pemphigoid","volume":"11","author":"Zakka","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2020.02.013_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1971.04000130003001","article-title":"Epidermolysis bullosa acquisita: report of three cases and review of all published cases","volume":"103","author":"Roenigk","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib171","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0190-9622(93)70164-O","article-title":"Bullous pemphigoid and autoimmunity","volume":"29","author":"Taylor","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib172","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","article-title":"The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan","volume":"9","author":"Ogawa","year":"1995","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib173","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/1346-8138.13079","article-title":"Malignancies in bullous pemphigoid: a controversial association","volume":"43","author":"Balestri","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib174","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","article-title":"The association of bullous pemphigoid and malignant disease: a case control study","volume":"123","author":"Venning","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1990.01670250072011","article-title":"Pemphigoid and cancer","volume":"126","author":"Lindelof","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib176","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamadermatol.2014.5263","article-title":"Association of bullous pemphigoid and malignant neoplasms","volume":"151","author":"Cai","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib177","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/jid.2014.547","article-title":"Malignancies\u00a0in pemphigus and pemphigoid diseases","volume":"135","author":"Schulze","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib178","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib179","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jid.2016.09.010","article-title":"Increased levels of the bullous pemphigoid BP180 autoantibody are associated with more severe dementia in Alzheimer\u2019s disease","volume":"137","author":"Kokkonen","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib181","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cne.20549","article-title":"Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system","volume":"487","author":"Claudepierre","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jaci.2020.02.013_bib182","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1346-8138.13207","article-title":"Bullous pemphigoid: what\u2019s ahead?","volume":"43","author":"Furue","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib183","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.17882","article-title":"Presence of anti-BP180 and anti-BP230 in the cerebrospinal fluid of patients with bullous pemphigoid and neurological disease: is there any intrathecal synthesis?","volume":"181","author":"Meudec","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib184","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","article-title":"New insights into the pathogenesis of bullous pemphigoid: 2019 update","volume":"10","author":"Genovese","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib185","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous\u00a0pemphigoid and herpes gestationis autoantibodies recognize a common\u00a0non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib186","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib187","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1523-1747.ep12507222","article-title":"An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement","volume":"78","author":"Gammon","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib188","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib189","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.188.3.475","article-title":"Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid","volume":"188","author":"Liu","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib191","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.matbio.2011.09.003","article-title":"Neutrophil elastase cleaves the murine hemidesmosomal protein BP180\/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid","volume":"31","author":"Lin","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jaci.2020.02.013_bib192","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib193","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00003-2015","article-title":"Trans-basement membrane migration of eosinophils induced by LPS-stimulated\u00a0neutrophils from human peripheral blood in vitro","volume":"1","author":"Nishihara","year":"2015","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaci.2020.02.013_bib194","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib195","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib196","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2020.02.013_bib197","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib198","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjd.14411","article-title":"Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies","volume":"175","author":"Dainichi","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib199","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archderm.1974.01630090016003","article-title":"IgE levels in sera of patients\u00a0with pemphigus or bullous pemphigoid","volume":"110","author":"Arbesman","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib201","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2016.03.009","article-title":"High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoid","volume":"83","author":"Cho","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib202","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane\u00a0pemphigoid: a useful clue for diagnosis","volume":"165","author":"Yayli","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib203","doi-asserted-by":"crossref","unstructured":"Kamata A, Kurihara Y, Funakoshi T, Takahashi H, Kuroda K, Hachiya T, et\u00a0al. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results [published online ahead of print July 2, 2019]. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.18364.","DOI":"10.1111\/bjd.18364"},{"key":"10.1016\/j.jaci.2020.02.013_bib204","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship\u00a0to\u00a0clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1523-1747.ep13070476","article-title":"A 230-kD basic protein is the major bullous pemphigoid antigen","volume":"92","author":"Mueller","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib207","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/1523-1747.ep12471985","article-title":"Comparative study of bullous pemphigoid antigens among Japanese, British, and U.S. patients indicates similar antigen profiles with the 170-kD antigen present both in the basement membrane and on the keratinocyte cell membrane","volume":"100","author":"Hashimoto","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib208","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib209","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib210","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2340\/00015555-1848","article-title":"Characterization of two cases of bullous pemphigoid reactive only with BP230 on Japanese enzyme-linked immunosorbent assays","volume":"94","author":"Sasai","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib211","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2020.02.013_bib212","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Le Jan","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib213","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.jaci.2020.02.013_bib214","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.oooo.2013.12.402","article-title":"Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing","volume":"117","author":"Hayakawa","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jaci.2020.02.013_bib215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41374-018-0113-9","article-title":"The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies","volume":"99","author":"Kamaguchi","year":"2019","journal-title":"Lab Investig"},{"key":"10.1016\/j.jaci.2020.02.013_bib216","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1523-1747.2000.00829.x","article-title":"Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model","volume":"114","author":"Lazarova","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib217","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1172\/JCI118942","article-title":"Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice","volume":"98","author":"Lazarova","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib218","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/clim.2000.4845","article-title":"Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice","volume":"95","author":"Lazarova","year":"2000","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"10.1016\/j.jaci.2020.02.013_bib219","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.4049\/jimmunol.176.3.1968","article-title":"Identification of an epitope within human\u00a0integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid","volume":"176","author":"Rashid","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib220","first-page":"2283","article-title":"The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid","volume":"40","author":"Chan","year":"1999","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib221","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1167\/iovs.12-11404","article-title":"Identification of epitopes within integrin beta4 for binding of auto-antibodies in ocular cicatricial and mucous membrane pemphigoid: preliminary report","volume":"54","author":"Rashid","year":"2013","journal-title":"Investig Ophthalmol Visual Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib222","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/jid.2015.51","article-title":"Autoantibodies to multiple epitopes on the non-collagenous-1 domain of type VII collagen induce blisters","volume":"135","author":"Vorobyev","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib223","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib224","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.0022-202X.2005.23702.x","article-title":"Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita","volume":"124","author":"Woodley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.jaci.2020.02.013_bib226","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.177.5.3461","article-title":"Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice","volume":"177","author":"Sitaru","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/path.4023","article-title":"Genetic identification and functional validation of FcgammaRIV as key molecule in autoantibody-induced tissue injury","volume":"228","author":"Kasperkiewicz","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.jaci.2020.02.013_bib228","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib229","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2020.02.013_bib230","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2020.02.013_bib231","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0190-9622(09)80149-7","article-title":"Burn-induced bullous pemphigoid","volume":"30","author":"Vassileva","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib232","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jdcr.2017.09.032","article-title":"Unilateral, localized bullous pemphigoid in a patient with chronic venous stasis","volume":"4","author":"Shi","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2020.02.013_bib233","doi-asserted-by":"crossref","DOI":"10.5070\/D3221029800","article-title":"Radiation-induced localized bullous pemphigoid in a patient with breast carcinoma","volume":"22","author":"Campa","year":"2016","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaci.2020.02.013_bib234","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdcr.2017.01.009","article-title":"Bullous pemphigoid localized in a primarily hemiplegic distribution","volume":"3","author":"Dreyer","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaci.2020.02.013_bib235","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0190-9622(95)90092-6","article-title":"Dyshidrosiform pemphigoid","volume":"32","author":"Scola","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib236","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib237","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/bjd.16479","article-title":"Unique clinical and serological features of bullous pemphigoid associated\u00a0with dipeptidyl peptidase-4 inhibitors","volume":"178","author":"Horikawa","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib238","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3389\/fimmu.2019.01224","article-title":"Preferential reactivity of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid autoantibodies to the processed extracellular domains of BP180","volume":"10","author":"Mai","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib239","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib241","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jdv.13889","article-title":"Exploring beyond the oral mucosa in patients affected with autoimmune blistering diseases: the importance of endoscopic procedures","volume":"31","author":"Espana","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.02.013_bib242","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human\u00a0BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib243","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/jdi.12877","article-title":"Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: a retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients","volume":"10","author":"Kawaguchi","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jaci.2020.02.013_bib244","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","article-title":"Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients","volume":"62","author":"Saleh","year":"2011","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib246","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ijd.14270","article-title":"Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up","volume":"58","author":"Kalinska-Bienias","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib247","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1346-8138.2005.tb00849.x","article-title":"Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone","volume":"32","author":"Motegi","year":"2005","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib248","first-page":"259","article-title":"Evaluation of tetracycline in the neutrophil chemotactic response","volume":"90","author":"Majeski","year":"1977","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib249","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2010.10.007","article-title":"Clinical applications of non-antimicrobial tetracyclines in dermatology","volume":"63","author":"Monk","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaci.2020.02.013_bib250","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.117.3.797","article-title":"Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor","volume":"117","author":"Burger","year":"1976","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmcl.2018.11.031","article-title":"The development of myeloperoxidase inhibitors","volume":"29","author":"Galijasevic","year":"2019","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.jaci.2020.02.013_bib252","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/1346-8138.15111","article-title":"Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)","volume":"46","author":"Ujiie","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib253","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2016.11.003","article-title":"A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid","volume":"85","author":"Amagai","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib254","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib255","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists\u2019 guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib256","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib257","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/jid.2013.236","article-title":"Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients","volume":"133","author":"Hall","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib258","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib259","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40257-018-0401-6","article-title":"Rituximab and omalizumab for the treatment of bullous pemphigoid: a systematic review of the literature","volume":"20","author":"Kremer","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib261","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/pde.13971","article-title":"Childhood ocular mucous membrane pemphigoid successfully treated with rituximab","volume":"36","author":"Flores-Climente","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib262","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fimmu.2018.00248","article-title":"Effectiveness and\u00a0safety of rituximab in recalcitrant pemphigoid diseases","volume":"9","author":"Lamberts","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.02.013_bib263","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib264","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1111\/j.1365-2230.2009.03608.x","article-title":"Refractory epidermolysis bullosa acquisita: successful treatment with rituximab","volume":"34","author":"Saha","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib265","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1346-8138.2011.01360.x","article-title":"Successful treatment of epidermolysis bullosa acquisita with rituximab therapy","volume":"39","author":"Kim","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib266","doi-asserted-by":"crossref","first-page":"e12726","DOI":"10.1111\/dth.12726","article-title":"The use of rituximab in treatment of epidermolysis bullosa acquisita: three new cases and a review of the literature","volume":"31","author":"Bevans","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaci.2020.02.013_bib267","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/pde.12006","article-title":"A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy","volume":"31","author":"McKinley","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib268","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11684-015-0388-9","article-title":"Th17 cells in autoimmune diseases","volume":"9","author":"Han","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.jaci.2020.02.013_bib269","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.mehy.2009.10.038","article-title":"Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid","volume":"74","author":"Toosi","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jaci.2020.02.013_bib270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2016.04.009","article-title":"Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid","volume":"83","author":"Fang","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2020.02.013_bib271","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2019.03.049","article-title":"Rituximab therapy in patients with bullous pemphigoid: a retrospective study of 20 patients","volume":"81","author":"Polansky","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib272","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils mediate tissue injury in the autoimmune skin disease bullous pemphigoid","volume":"138","author":"Lin","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.02.013_bib273","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI119234","article-title":"Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice","volume":"99","author":"Mould","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.02.013_bib274","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.smim.2018.03.002","article-title":"The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin","volume":"37","author":"Sadik","year":"2018","journal-title":"Semin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920302669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920302669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:03:16Z","timestamp":1777474996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920302669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":274,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0091674920302669"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.02.013","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune bullous skin diseases, pemphigus and pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}